TDP-43 is not a common cause of sporadic amyotrophic lateral sclerosis

PLoS ONE

Volumn 3, Issue 6, 2008, Pages

  Guerreiro, Rita J ^a,b   Schymick, Jennifer C ^a,c   Crews, Cynthia ^a   Singleton, Andrew ^a   Hardy, John ^d   Traynor, Bryan J ^a,e  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; TAR DNA BINDING PROTEIN 43; PROTEIN TDP 43; PROTEIN TDP-43;

ADULT; AFRICA; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CONTROLLED STUDY; EUROPE; FEMALE; GENE LOCUS; GENE SEQUENCE; GENE STRUCTURE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; SINGLE NUCLEOTIDE POLYMORPHISM; COHORT ANALYSIS; GENETICS; MIDDLE AGED; MUTATION; PATHOPHYSIOLOGY; PHYSIOLOGY; STATISTICAL MODEL;

ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; COHORT STUDIES; DNA-BINDING PROTEINS; GENOTYPE; HAPLOTYPES; HUMANS; LIKELIHOOD FUNCTIONS; MIDDLE AGED; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 48749087900     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002450     Document Type: Article

References (30)

1. Logroscino G, et al. (2005) Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study. Journal of neurology, neurosurgery, and pychiatry 76: 1094-8.
2. Chiò A, Traynor BJ, Lombardo F, Fimognari M, Calvo A, et al. (February 12, 2008) Prevalence of SOD1 mutations in the Italian ALS population. Neurology 70: 533-7.
3. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, et al. (March 4, 1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362: 59-6210.1038/ 362059a0.
4. Puls I, Jonnakuty C, LaMonte BH, Holzbaur EL, Tokito M, et al. (April 2003) Mutant dynacLin in motor neuron disease. Nat Genet 33: 455-45610.1038/ng1123.
5. Münch C, Sedlmeier R, Meyer T, Homberg V, Sperfeld A, et al. (2004) Point mutations of the p150 subunit or dynactin (DCTN1) gene ALS. Neurology 63: 724-726.
6. Hadano S, Hand CK, Osuga H, Yanagisawa Y, Otomo A, et. al. (October 2001) A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat Genet 29: 166-17310.1038/ng1001-166.
7. Chen Y, Bennett CL, Huytth HM, Blair rP, Puls I, et al. (June 2004) DNA/ RNA Helicase Gene Mutations in a Form of Juvenile Amyotrophic Lateral Sclerosis (ALS4). The American Journal of Human Genetics 74: 1128-113510.1086/421054.
8. Nishimura AL, Mitne-Neto M, Silva HC, Richieri-Costa A, Middleton S, et al. (November 2004) A Mutation in the Vesicle-Trafficking Protein VAPB Causes Late-Onset Spinal Muscular Atrophy and Amyotrophic Lateral Sclerosis. The American Journal of Human Genetics 75: 822-83110.1086/ 425287.
9. Schymick JC, Scholz SW, Fung H, Britton A, Arepalli S, et al. (April 2007) Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol 322-8.
10. Leigh PN, Whitwell H, Garofalo O, Buller J, Swash M, et al. (April 1991) Ubiquitin-immunoreactive intrancuronal inclusions in amyotrophic lateral sclerosis. Morphology, distribution, and specificity. Brain 114 (Pt 2): 775-88.
11. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, et al. (October 2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 6 314: 130-3.
12. Mackenzie IRA, Bigio EH, Ince PG, Geser F, Neumann M, et al. (May 2007) Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol 61: 427-34.
13. Robertson J, Sanelli T, Xiao S, Yang W, Horne P, et al. (June 13, 2007) Lack of TDP-43 abnormalities in mutant SOD1 transgenic mice shows disparity with ALS. Neurosci Lett 420: 128-32.
14. Wang H, Wang I, Bose J, Shen CJ (January 2004) Structural diversity and functional implications of the eukaryotic TDP gene family. Genomics 83: 130-9.
15. Ou SH, Wu F, Harrich D, García-Martínez LF, Gaynor RB (June 1995) Cloning and characterization of a novel cellular protein, TDPA 3, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J Virol 69: 3584-96.
16. Buratti E, Brindisi A, Giombi M, Tisminetzky S, Ayala YM, et al. (November 11, 2005) TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: an important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing. J Biol Chem 280: 37572-84.
17. Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, et al. (March 21, 2008) TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319: 1668-72.
18. Gitcho MA, Baloh R.H, Chakraverty S, Mayo K, NortonjB, et al. (February 20, 2008) TDP-43 A315T mutation in familial motor neuron disease. Ann Neurol.
19. Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, et al. (March 30, 2008) TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet.
20. Van Deerlin VM, Leverenz JB, Bekris LM, Bird TD, Yuan W, et al. (April 4, 2008) TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol.
21. Brooks BR, Miller RG, Swash M, Munsat TL (December 2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1: 293-9.
22. Cann HM, de Toma C, Cazes L, Legrand M, Morel V, et al. (April 12, 2002) A human genome diversity cell fine panel. Science 296: 261-2.
23. Fung H, Scholz S, Matarin M, Simón-Sánchez J, Hernandez D, et al. (November 2006) Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data. Lancet Neurcil 5: 911-6.
24. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, et al. (September 2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-75.
25. Tan C, Eguchi H, Tagawa A, Onodera O, Iwasaki T, et al. (May 2007) TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation. Acta Neuropathol 113: 535-42.
26. Winton MJ, Igaz LM, Wong MM, Kwong LK, Trojanowski JQ et al. (February 27, 2006) Disturbance of nuclear and cytoplasmic Tar DNA binding protein (TDP-43) induces disease-like redistribution, sequestration and aggregate formation. J Biol Chem.
27. Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, et al. (February 22, 2008) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351: 602-11.
28. Gijselinck I, Sleegers K, Engelborghs S, Robberecht W, Martin J, et al. (December 7, 2007) Neuronal inclusion protein TDP-43 has no primary genetic role in FTD and ALS. Neurobiol Aging.
29. Rosenberg NA, Pritchard JK, Weber JL, Cann HM, Kidd KK, et al. (December 20, 2002) Genetic structure of human populations. Science 298: 2381-5.
30. Watkins WS, Rogers AR, Ostler CT, Wooding S, Barrishad MJ, et al. (July 2003) Genetic variation among world populations: inferences from 100 Alu insertion polymorphisms. Genome Res 13: 1607-18.